CDRH Contracts Review Cost Auditor; Expedited, Modular PMAs On The Rise
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is meeting review targets for expedited premarket applications, with just over a quarter of the fiscal 2004 cohort completed
You may also be interested in...
Second Year MDUFMA Stats Show Catch-Up Required To Achieve Cycle Goals
FDA forecasts that decision goals under the Medical Device User Fee & Modernization Act will be easier to meet than cycle goals, based on a comparison of fiscal 2003 and 2004 performance data with FY 2005 statutory benchmarks
Second Year MDUFMA Stats Show Catch-Up Required To Achieve Cycle Goals
FDA forecasts that decision goals under the Medical Device User Fee & Modernization Act will be easier to meet than cycle goals, based on a comparison of fiscal 2003 and 2004 performance data with FY 2005 statutory benchmarks
Girding For MDUFMA II: Premarket Review Unit Cost Study In Planning Phase
FDA's unit cost analysis of premarket review resources may incite a long-term change to device user fee rates if certain application types prove more expensive to assess than previously believed